These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 4156327)

  • 1. Antilymphocytic antibodies and marrow transplantation. IV. Comparison of the effects of antibody fragments directed against immunoglobulin or lymphocyte antigens on acute secondary disease.
    Rodt H; Therfelder S; Eulitz M
    Exp Hematol; 1974; 2(4):195-203. PubMed ID: 4156327
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-lymphocytic antibodies and marrow transplantation. 3. Effect of heterologous anti-brain antibodies on acute secondary disease in mice.
    Rodt H; Thierfelder S; Eulitz M
    Eur J Immunol; 1974 Jan; 4(1):15-9. PubMed ID: 4152781
    [No Abstract]   [Full Text] [Related]  

  • 3. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of graft-versus-host disease by Fab fragments derived from ALG.
    Richie ER; Gallagher MT; Trentin JJ
    Transplant Proc; 1973 Mar; 5(1):873-6. PubMed ID: 4144467
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of the graft-versus-host reaction. I. Reduction of the graft-versus-host potential of mouse spleen cells (with a sparing of stem cells) by treatment with antilymphocyte globulin-derived Fab fragments.
    Gallagher MT; Richie ER; Heim LR; Judd KP; Trentin JJ
    Transplantation; 1972 Nov; 14(5):597-602. PubMed ID: 4404282
    [No Abstract]   [Full Text] [Related]  

  • 6. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
    Thierfelder S; Cobbold S; Kummer U; Waldmann H; Schuh R
    Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antilymphocytic antibodies and marrow transplantation. V. Suppression of secondary disease by host-versus-theta-graft reaction.
    Thierfelder S; Rodt H
    Transplantation; 1977 Jan; 23(1):87-92. PubMed ID: 319574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed secondary disease in mice after early or late therapy with anti-thymocyte serum.
    Kinnamon KE; Blackwell LH; Ledney GD
    Exp Hematol; 1973; 1(4):202-14. PubMed ID: 4154088
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of graft-versus-host-reaction (GVHR) by in vitro incubation of donor lymphocytes with thymic or splenic chalone (s).
    Kiger N; Florentin I; Garcia-Giralt E; Mathé G
    Exp Hematol; 1973; 1(1):22-8. PubMed ID: 4153630
    [No Abstract]   [Full Text] [Related]  

  • 10. Graft-versus-host-induced immunosuppression. The effect of antigenic stimulation on cell-mediated and humoral immune responses.
    Treiber W; Lapp WS
    Transplantation; 1973 Sep; 16(3):211-6. PubMed ID: 4147031
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of the graft-versus-host reaction. III. Altered in vivo distribution of spleen cells pretreated with Fab fragments of antithymocyte globulin.
    Richie ER; Monié HJ; Trentin JJ; Taub RN
    Transplantation; 1975 Feb; 19(2):115-20. PubMed ID: 235162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft versus leukemia. 3. Apparent independent anthost and antileukemia activity of transplanted immunocompetent cells.
    Bortin MM; Rimm AA; Saltzstein EC; Rodey GE
    Transplantation; 1973 Sep; 16(3):182-8. PubMed ID: 4147030
    [No Abstract]   [Full Text] [Related]  

  • 13. Mouse bone marrow lymphocytes and their differentiation.
    Ryser JE; Vassalli P
    J Immunol; 1974 Sep; 113(3):719-28. PubMed ID: 4213258
    [No Abstract]   [Full Text] [Related]  

  • 14. Progress in the prevention of GVH: bone marrow grafts after ALG conditioning, with lymphocyte split chimerism, use of a lymphocyte "chalone T", and soluble histocompatibility antigens.
    Mathé G; Kiger N; Florentin I; Garcia-Giralt E; Martyre MC; Halle-Pannenko O; Schwartzenberg L
    Transplant Proc; 1973 Mar; 5(1):933-9. PubMed ID: 4144474
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone marrow transplantation in inbred strains of mice. I. The failure of development of normal T cell function following allogeneic transplantation.
    Trier L; Rubin B
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Oct; 82B(5):724-32. PubMed ID: 4139875
    [No Abstract]   [Full Text] [Related]  

  • 16. [Participation of phytohemagglutinin-transformed mouse lymphocytes in development of the "graft-versus-host" reaction].
    Nesterenko VG; Koval'chuk LV
    Biull Eksp Biol Med; 1976 Sep; 82(9):1096-8. PubMed ID: 11013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific inactivation of lymphoid cells in bone marrow grafts.
    Müller-Ruchholtz W; Müller-Hermelink HK; Sonntag HG
    Transplant Proc; 1973 Mar; 5(1):877-80. PubMed ID: 4144468
    [No Abstract]   [Full Text] [Related]  

  • 18. Specific unresponsiveness to skin allografts in mice. II. The mechanism of unresponsiveness induced by tissue extracts and antilymphocytic serum.
    Kilshaw PJ; Brent L; Thomas AV
    Transplantation; 1974 Jan; 17(1):57-69. PubMed ID: 4148889
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunogenetic disparity and graft-versus-host reactions.
    Bach ML; Bach FH
    Semin Hematol; 1974 Jul; 11(3):291-303. PubMed ID: 4151845
    [No Abstract]   [Full Text] [Related]  

  • 20. The double barrier in bone marrow transplantation.
    van Bekkum DW
    Semin Hematol; 1974 Jul; 11(3):325-40. PubMed ID: 4151846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.